Research Frontiers vs VirnetX
REFR and VHC side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How REFR and VHC compare
VirnetX is the larger company, worth 3.4 times as much as Research Frontiers ($42.1M against $12.3M).
VirnetX grew revenue faster over the last twelve months (128% versus −69.7% for Research Frontiers).
Research Frontiers keeps more of each dollar of sales as profit, with a net margin of −662% compared with −17374% at VirnetX.
VirnetX scores higher on the StockData Score (8 against 6 for Research Frontiers), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | REFR | VHC |
|---|---|---|
| Size and price | ||
| Market cap | $12.3M | $42.1M |
| Share price | $0.353 | $9.99 |
| Change, 1 year | −77.5% | −57.0% |
| Change, 5 years | −83.4% | −86.7% |
| Beta (5Y) | 0.35 | 1.07 |
| Employees | 5 | 13 |
| StockData Score | ||
| Total score | 6 | 8 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 33.1× (better) | 370× |
| P/B | 20.1× | 2.8× (better) |
| FCF yield | −15.1% | – |
| Fair value | $0.159 | – |
| Margin of safety | −122% | – |
| Growth | ||
| Revenue growth (TTM) | −69.7% | 128% (better) |
| Revenue growth, 5Y average | 6.2% (better) | −77.8% |
| Profitability | ||
| Operating margin | −670% (better) | −18078% |
| Net margin | −662% (better) | −17374% |
| FCF margin | −500% | – |
| Return on equity | −233% | −82.1% (better) |
| Return on invested capital | −1167% | −1044% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.21 | 6.24 (better) |
| Altman Z-score | −90.63 | −13.27 (better) |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 10.5% | 13.9% |
| Held by insiders | 8.9% | 17.5% |
| Insider net buying, 12 months | – | −$489K |
| Short interest, % of float | 1.2% | 3.9% |
Go deeper
- REFR stock overview
- REFR income statement
- REFR valuation and score
- VHC stock overview
- VHC income statement
- VHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.